 0 Table of Contents |
  1 Patient Monitoring Outcome Home Page |
  2 General Recommendations |
  3 Terminologies |
  4 Overview Carepaths |
  5 Carepath Heart failure |
  6 Carepath Holter Monitoring |
  7 Carepath NEWS (National Early Warning Score) |
  8 Carepath TOTeM |
  9 Carepath OPAT |
  10 Carepath Antitumoral therapy |
  11 Carepath Perioperative care - abdominal |
  12 Overview carepath LOINC |
  13 Overview caresets |
  14 Special careset - home hospitalization |
  15 Home hosp - OPAT |
  16 Home hosp - Antitumoral therapy |
  17 Home hosp - Mappingtables |
  18 Useful Downloads |
  19 Acknowledgments, licenses and copyrights |
  20 IG Change History |
  21 Artifacts Summary |
   21.1 Home Hospitalization Encounter Logical Model |
   21.2 Home Hospitalization QuestionnaireResponse Logical Model |
   21.3 ONCO Azacitidine Questionnaire Logical Model |
   21.4 ONCO Bortezomib Questionnaire Logical Model |
   21.5 ONCO Daratumumab Questionnaire Logical Model |
   21.6 ONCO Fulvestrant Questionnaire Logical Model |
   21.7 ONCO Trastuzumab Questionnaire Logical Model |
   21.8 OPAT Continuous Infusion Questionnaire Logical Model |
   21.9 OPAT Short IV Questionnaire Logical Model |
   21.10 Questionnaire: Azacitidine Home Hospitalization |
   21.11 Questionnaire: Bortezomib Home Hospitalization |
   21.12 Questionnaire: Daratumumab Home Hospitalization |
   21.13 Questionnaire: Fulvestrant Home Hospitalization |
   21.14 Questionnaire: OPAT Continuous Infusion Home Hospitalization |
   21.15 Questionnaire: OPAT Short IV Home Hospitalization |
   21.16 Questionnaire: Trastuzumab Home Hospitalization |
   21.17 Appetite Observation |
   21.18 Bladder Continence Observation |
   21.19 Clinical Note Observation |
   21.20 Drain Fluid Observation |
   21.21 Holter Diagnostic Report |
   21.22 Holter Observation |
   21.23 Home Hospitalization Careset Encounter |
   21.24 Home Hospitalization Careset Questionnaire Response |
   21.25 Nausea Observation |
   21.26 ONCO Azacitidine Nursing Questionnaire |
   21.27 ONCO Bortezomib Nursing Questionnaire |
   21.28 ONCO Daratumumab Nursing Questionnaire |
   21.29 ONCO Fulvestrant Nursing Questionnaire |
   21.30 ONCO Home Hospitalization Base Questionnaire |
   21.31 ONCO Trastuzumab Nursing Questionnaire |
   21.32 OPAT Continuous Infusion Nursing Questionnaire |
   21.33 OPAT Home Hospitalization Base Questionnaire |
   21.34 OPAT Short-Duration IV Nursing Questionnaire |
   21.35 Painkiller Usage Observation |
   21.36 Stool Observation |
   21.37 Surgical Wound Pain Observation |
   21.38 Wexner/CCIS Score Observation |
   21.39 0-10 scale, 0.5 increments, Very well to Very poor |
   21.40 Catheter Lumen Color |
   21.41 Catheter Patency Scale |
   21.42 Catheter Type |
   21.43 Continence Level |
   21.44 Fluid Drain Value Set |
   21.45 Heart Failure Symptom Codes |
   21.46 Holter Event Codes |
   21.47 Holter Observation Component Codes |
   21.48 Holter Report Code |
   21.49 Home Hospitalization Side Effect Severity Scale |
   21.50 Medication Administration Decision |
   21.51 Medication Storage Status |
   21.52 Normal / Abnormal Finding |
   21.53 ONCO Symptom Grade Scale (CTCAE 0–3) |
   21.54 Pain severity - 0-10 verbal numeric rating |
   21.55 Symptom Severity Scale |
   21.56 True / False Value Set |
   21.57 Yes / No Value Set |
   21.58 Medication Administration Decision Codes |
   21.59 Appointment: OPAT Hospital Follow-up |
   21.60 CareTeam: Catheter |
   21.61 CareTeam: Emergency |
   21.62 CareTeam: Home Hospitalization |
   21.63 CareTeam: OPAT |
   21.64 ClinicalImpression: Relevant Medical History |
   21.65 ClinicalImpression: Symptom - Blisters |
   21.66 ClinicalImpression: Symptom - Candidiasis |
   21.67 ClinicalImpression: Symptom - Chills |
   21.68 ClinicalImpression: Symptom - Constipation |
   21.69 ClinicalImpression: Symptom - Diarrhea |
   21.70 ClinicalImpression: Symptom - Fatigue |
   21.71 ClinicalImpression: Symptom - Itching |
   21.72 ClinicalImpression: Symptom - Joint Pain |
   21.73 ClinicalImpression: Symptom - Nausea |
   21.74 ClinicalImpression: Symptom - Other |
   21.75 ClinicalImpression: Symptom - Other (Specify) |
   21.76 ClinicalImpression: Symptom - Pain |
   21.77 ClinicalImpression: Symptom - Rash |
   21.78 ClinicalImpression: Symptom - Reduced Appetite |
   21.79 ClinicalImpression: Symptom - Respiratory Problems |
   21.80 ClinicalImpression: Symptom - Swelling |
   21.81 ClinicalImpression: Symptom - Vomiting |
   21.82 Composition: OPAT Document |
   21.83 DiagnosticReport: Holter |
   21.84 Encounter: Home Hospitalization (Subcutaneous Injection) |
   21.85 Encounter: OPAT Consultation |
   21.86 Location: UZL Consultation |
   21.87 Observation: Abdominal Pain |
   21.88 Observation: Appetite |
   21.89 Observation: Bladder Continence |
   21.90 Observation: Blood Pressure |
   21.91 Observation: Blood Pressure (Without Device) |
   21.92 Observation: Body Temperature |
   21.93 Observation: Body Temperature (OPAT Document) |
   21.94 Observation: Body Temperature (Without Device) |
   21.95 Observation: Body Weight |
   21.96 Observation: Body Weight (Registered by Patient) |
   21.97 Observation: Bristol Stool Form Score |
   21.98 Observation: Catheter (OPAT Document) |
   21.99 Observation: Catheter Moved or Removed |
   21.100 Observation: Clinical Note |
   21.101 Observation: Diarrhea |
   21.102 Observation: Distended Abdomen |
   21.103 Observation: Drain Fluid Output |
   21.104 Observation: Heart Rate |
   21.105 Observation: Heart Rate (Registered by Patient) |
   21.106 Observation: Holter AFib Episode |
   21.107 Observation: Holter Supraventricular Event |
   21.108 Observation: Leakage Catheter |
   21.109 Observation: Level of Responsiveness |
   21.110 Observation: National Early Warning Score (NEWS) |
   21.111 Observation: Nausea |
   21.112 Observation: Nausea (2) |
   21.113 Observation: Orthopnea |
   21.114 Observation: Oxygen Saturation |
   21.115 Observation: Oxygen Saturation (Registered by Patient) |
   21.116 Observation: Pain at Infection Site |
   21.117 Observation: Pain at Puncture Wounds |
   21.118 Observation: Pain at Surgical Wounds |
   21.119 Observation: Pain at Surgical Wounds (2) |
   21.120 Observation: Pain During Urination |
   21.121 Observation: Pain in Calves |
   21.122 Observation: Painkiller Usage |
   21.123 Observation: Redness at Puncture Wounds |
   21.124 Observation: Reduced Appetite |
   21.125 Observation: Respiratory Rate |
   21.126 Observation: Respiratory Rate (Registered by Patient) |
   21.127 Observation: Shortness of Breath |
   21.128 Observation: Shoulder Pain |
   21.129 Observation: Wexner/CCIS Incontinence Score |
   21.130 Organization: UZ Leuven |
   21.131 Patient: OPAT Home Hospitalization |
   21.132 PractitionerRole: General Practitioner |
   21.133 Questionnaire: ONCO SDC Questionnaire with Extraction Definitions (Trastuzumab) |
   21.134 Questionnaire: OPAT SDC Questionnaire with Extraction Definitions |
   21.135 QuestionnaireResponse: Azacitidine Home Hospitalization |
   21.136 QuestionnaireResponse: OPAT continuous infusion QR - 2-lumen tunneled catheter |
   21.137 QuestionnaireResponse: OPAT Home Hospitalization - continuous infusion |
   21.138 QuestionnaireResponse: OPAT short IV QR - 3-lumen tunneled catheter |